RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @RinconDocenteMF: J.J. McNeil (NEJM) En adultos >70 años sanos sin indicación de aspirina la mortalidad por todas las causas fue aparent…
Healthy over 70 year-olds don’t benefit from #aspirin as primary prevention https://t.co/GYSTvqWNlK Adverse effect size is small however - number needed to harm is over 600
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
“En mayores sanos de 70 años o más, que tomaban AAS en prevención primaria tubieron mayor mortalidad que aquellos que que sólo reciben placebo” #PrimummNonNocere
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | NEJM https://t.co/sTYYz0BO5o
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
La aspirina diaria, al menos no es mejor y eventualmente peor. 100 mg/día de ASA en adultos mayores, no enfermos, hacia el 4-5 años presentan un riesgo apenas estadísticamente significativo (clínicamente no definido) de mortalidad x cancer. Ups, pago por v
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
"Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who received placebo and was attributed primarily to cancer-related death." https://t.co/IQyed9kj0k
I always wonder about primary prevention. I think we need to look harder at subgroups and comorbidities
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
RT @NEJM: ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin…
ASPREE trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/Cn2Ot9f1ka Editorial: Should Aspirin Be Used for Primary Prevention in the Post-Statin Era? https://t.co/NzO4IcMndP https://t.co/IWu8iqdV5q
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly. MENOS ES MAS | NEJM https://t.co/O7XMNIk8YB
Astonishing: Higher all-cause mortality was observed among apparently healthy older adults who received #Aspirin @SOGAPAR https://t.co/yzzDNBvxBV
Ojo con la aspirineta Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | NEJM https://t.co/0sg0zV897g
I think the most rational conclusion from this data is that patients with cancer on asa have higher mortality rates than those with cancer who took placebo. Nothing else ! What do you think?
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
Quizas no todo está tan claro sobre profilaxis primaria de mortalidad y Aspirin @NEJM https://t.co/MXjaj4jZht
RT @jvillacastin: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | NEJM https://t.co/pjDJokLY2v
RT @jvillacastin: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | NEJM https://t.co/pjDJokLY2v
RT @jvillacastin: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | NEJM https://t.co/pjDJokLY2v
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | NEJM https://t.co/eII7IgcQfw
⏩⏩ Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://t.co/d6chF8D4Xr
La aspirina aumenta la mortalidad utilizada diariamente en ancianos sin enfermedad cardiovascular, demencia o discapacidad. Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | NEJM https://t.co/1Vgtgd8oD6
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | NEJM https://t.co/pgWi7qXANk. OJO, pudiera aumentar mortalidad por cáncer
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who received placebo and was attributed primarily to cancer-related death https://t.co/AicCMppEWZ
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | NEJM https://t.co/pjDJokLY2v
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who received placebo and was attributed primarily to cancer-related death. Full ASPREE trial results https://t.co/LA3NQOCEV3
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
For healthy elderly, #aspirin increased all- cause #mortality, had no effect on disability-free survival, did not lower #cardiovascular events. In diabetics, lower rates of vascular events were counterbalanced by higher hemorrhage risks. https://t.co/0qHb4
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…
RT @NEJM: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who rec…